Cargando…
Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus
Coronavirus disease 2019 (COVID-19) is a new pandemic the entire world is facing since December of 2019. Several risk factors are identified in developing severe disease and one of which is preexisting type 2 diabetes mellitus. Metformin is known to have host-directed anti-viral and anti-inflammator...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973653/ https://www.ncbi.nlm.nih.gov/pubmed/35365744 http://dx.doi.org/10.1038/s41598-022-09639-2 |